Re­ci­pharm to change CEOs, spin out in­haler busi­ness

Re­ci­pharm CEO Marc Funk is step­ping down at the be­gin­ning of next year, and a for­mer Nestlé ex­ec­u­tive is set to take over as chief ex­ec­u­tive as the CD­MO pre­pares to spin off its in­haler busi­ness.

Greg Be­har has been the CEO of Nestlé Health Sci­ence since Ju­ly 2014, and he has held pre­vi­ous lead­er­ship po­si­tions at No­var­tis and Boehringer In­gel­heim.

Funk has served as CEO of Re­ci­pharm since March 2021 and will join the com­pa­ny’s board. Funk will con­tin­ue as CEO and board mem­ber of Mar­Bio, Re­ci­pharm and Mo­roc­co’s joint vac­cine man­u­fac­tur­ing site ini­ti­at­ed in Ju­ly 2021. He will al­so re­main on the board of New­Bi­ologix, a cell line en­gi­neer­ing busi­ness launched in May and fund­ed by Re­ci­pharm.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER